HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice.

Abstract
The situation following anti-obesity drug termination is rarely investigated, eventhough a decrease in body weight needs to be sustained. Therefore, this study examined the impact of twice-daily peripheral administration of 5 mg/kg [N-palm-γGlu-Lys11] prolactin-releasing peptide 31 (palm11-PrRP31) in mice with diet-induced obesity (DIO from consuming a high-fat diet) after 28 days of treatment (palm11-PrRP31 group) and after 14 days of peptide treatment followed by 14 days of discontinuation (palm11-PrRP31 + saline group). At the end of the treatment, cumulative food intake, body weight and subcutaneous fat weight/body weight ratio and leptin plasma level were reduced significantly in both the palm11-PrRP31 group and the palm11-PrRP31 + saline group compared to the saline control group. This reduction correlated with significantly increased FOSB, a marker of long-term neuronal potentiation, in the nucleus arcuatus and nucleus tractus solitarii, areas known to be affected by the anorexigenic effect of palm11-PrRP31. Moreover, activation of leptin-related hypothalamic signaling was registered through an increase in phosphoinositide-3-kinase, increased phosphorylation of protein kinase B (PKB, AKT) and enhanced extracellular signal-regulated kinase 1/2 phosphorylation. Besides, lowered apoptotic markers c-JUN N-terminal kinase and c-JUN phosphorylation were registered in the hypothalami of both palm11-PrRP31-treated groups. This study demonstrates that palm11-PrRP31 positively affects feeding and leptin-related hypothalamic signaling, not only after 28 days of treatment but even 14 days after the termination of a 14-day long treatment without the yo-yo effect.
AuthorsMartina Holubová, Lucie Hrubá, Barbora Neprašová, Zuzana Majerčíková, Zdeňka Lacinová, Jaroslav Kuneš, Lenka Maletínská, Blanka Železná
JournalJournal of molecular endocrinology (J Mol Endocrinol) Vol. 60 Issue 2 Pg. 85-94 (02 2018) ISSN: 1479-6813 [Electronic] England
PMID29233862 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 Society for Endocrinology.
Chemical References
  • Leptin
  • Prolactin-Releasing Hormone
  • RNA, Messenger
  • Receptors, Leptin
Topics
  • Animals
  • Apoptosis
  • Eating
  • Fasting (blood)
  • Humans
  • Hypothalamus (metabolism)
  • Leptin (metabolism)
  • Male
  • Mice, Inbred C57BL
  • Mice, Obese
  • Neurons (metabolism)
  • Organ Size
  • Phosphorylation
  • Prolactin-Releasing Hormone (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Receptors, Leptin (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: